Sector: health
Conviction from: S&PCitrini
52-week range: 81.22171.74
Revvity, formerly PerkinElmer, provides life sciences and diagnostics products and services, including reagents, instruments, and testing solutions for research and healthcare.
3 tracked filer(s) hold this · 2 opened, 1 added, 0 trimmed in 30-SEP-2026
Aggregate 13FScore 53 — mean of 3 scored holder(s) · buyers (new/add) avg 53. Higher = the smart money in this name has the better track record.
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
1 disclosed trade(s) by 1 filer(s).
| Report | Date | Stance |
|---|
| #135 — State of the Themes: The End of the Trade (As We Know It) | 2026-11-04 | LONG |
| #134 — Citrini Therapeutics: We Wanted to Use Claude to Create a New Drug | 2026-10-20 | LONG |